A venture capital firm based in Texas and committed to enabling healthcare innovation is currently investing out of its latest fund of $200 million. The firm typically makes initial, equity investments of $10M, with the possibility to allocate up to $35M over the life of the investment.
The firm is currently most interested in the medtech and healthcare IT space, specifically IT-enabled healthcare devices and services. The firm is not interested in traditional medical devices without a software/data-driven component. The firm is indication agnostic, but has particular interest in neurology, cardiology, pulmonology, hearing, and wound care.
The firm seeks to invest in revenue-generating companies with a minimum of $2M-$3M in revenues, although there are no EBIDTA requirements and it is not required that the company be cash-flow positive. The firm will also look at pre-revenue companies on a secondary basis, with the caveat being that there is a clear line of sight to revenue generation. The firm only invests in U.S.-based companies with clinical data.
If you are interested in more information about this investor and other investors tracked by LSN, please email firstname.lastname@example.org